“phaserx” Archives

Entry Author Date Location
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
PhaseRx Obtains $18,500,000 New Round 05/18/16 Seattle
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
PhaseRx Garners $1,400,014 New Financing Round 10/03/13 Seattle
PhaseRx Receives $500,005 New Funding Round 07/12/13 Seattle
PhaseRx Receives $1,500,016 New Financing 12/26/12 Seattle
PhaseRx Secures $5,200,053 New Round 07/09/12 Seattle
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News 03/10/11 Seattle
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Top 10 Northwest Venture Deals of the Third Quarter—and VC Color Commentary 10/20/09 Seattle
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies 08/25/09 Seattle
Tekmira Tackles RNAi Delivery Challenge, With Alnylam, Roche Putting It to the Test 05/26/09 Seattle
Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier 12/04/08 Seattle
Gov. Gregoire Urges Biotechies to “Stay Focused”; UW Makes its Biotech Business Case, And A Host of Startups Debut 10/28/08 Seattle
PhaseRx Lands $19,000,000 Series A Financing Round 02/28/08 Seattle
Page 1 of 1